4.78 USD
▲+0.01+0.21%
盘后 4.73 0.00%
2026-09-15
市值
$303.56M
市盈率
—
EPS
-1.15
股息率
—
52 周区间
2.20 – 7.95
成交量
162.50K
Beta
0.44
目标价
10.20
52W 低 2.2052W 高 7.95
价格走势
公司简介
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device...